wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39515202-5D0FD401-2EB0-4724-8F71-4CF6011A5927
Q39515202-5D0FD401-2EB0-4724-8F71-4CF6011A5927
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39515202-5D0FD401-2EB0-4724-8F71-4CF6011A5927
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials.
P2860
Q39515202-5D0FD401-2EB0-4724-8F71-4CF6011A5927
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39515202-5D0FD401-2EB0-4724-8F71-4CF6011A5927
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cead3ce6e3b11d4cf7b0b7fa0c53f4720e4fcf0a
P2860
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.